Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C15H20O2 |
| Molecular Weight | 232.3181 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C1CC2=CC=C(C=C2C1)C(C)C(O)=O
InChI
InChIKey=RYDUZJFCKYTEHX-UHFFFAOYSA-N
InChI=1S/C15H20O2/c1-9(2)13-7-12-5-4-11(6-14(12)8-13)10(3)15(16)17/h4-6,9-10,13H,7-8H2,1-3H3,(H,16,17)
| Molecular Formula | C15H20O2 |
| Molecular Weight | 232.3181 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
ISOPROFEN is an anti-inflammatory agent with analgesic and antipyretic properties. Its anti-inflammatory potency is greater than that of phenylbutazone but lower than that of indomethacin. Its antipyretic action can be explained by an effect of this substance on the metabolism of arachidonic acid in the brain.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The metabolic chiral inversion of 2-arylpropionic acids--a novel route with pharmacological consequences. | 1983-11 |
|
| Stereospecific inversion of configuration of 2-(2-isopropylindan-5-yl)-propionic acid in rats. | 1980-08 |
|
| Pharmacological properties of a new anti-inflammatory agent: 2-(2-isopropyl-5-indanyl)propionic acid (UP 517-03). | 1980 |
|
| The antipyretic effect of UP 517-03 in the rabbit. | 1979-12 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:29:31 GMT 2025
by
admin
on
Mon Mar 31 18:29:31 GMT 2025
|
| Record UNII |
18751GAD0P
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Mon Mar 31 18:29:31 GMT 2025 , Edited by admin on Mon Mar 31 18:29:31 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
57144-56-6
Created by
admin on Mon Mar 31 18:29:31 GMT 2025 , Edited by admin on Mon Mar 31 18:29:31 GMT 2025
|
PRIMARY | |||
|
C83845
Created by
admin on Mon Mar 31 18:29:31 GMT 2025 , Edited by admin on Mon Mar 31 18:29:31 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105045
Created by
admin on Mon Mar 31 18:29:31 GMT 2025 , Edited by admin on Mon Mar 31 18:29:31 GMT 2025
|
PRIMARY | |||
|
18751GAD0P
Created by
admin on Mon Mar 31 18:29:31 GMT 2025 , Edited by admin on Mon Mar 31 18:29:31 GMT 2025
|
PRIMARY | |||
|
68769
Created by
admin on Mon Mar 31 18:29:31 GMT 2025 , Edited by admin on Mon Mar 31 18:29:31 GMT 2025
|
PRIMARY | |||
|
100000082854
Created by
admin on Mon Mar 31 18:29:31 GMT 2025 , Edited by admin on Mon Mar 31 18:29:31 GMT 2025
|
PRIMARY | |||
|
SUB08331MIG
Created by
admin on Mon Mar 31 18:29:31 GMT 2025 , Edited by admin on Mon Mar 31 18:29:31 GMT 2025
|
PRIMARY | |||
|
DTXSID30866616
Created by
admin on Mon Mar 31 18:29:31 GMT 2025 , Edited by admin on Mon Mar 31 18:29:31 GMT 2025
|
PRIMARY | |||
|
4502
Created by
admin on Mon Mar 31 18:29:31 GMT 2025 , Edited by admin on Mon Mar 31 18:29:31 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |